Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

KIDS vs VREX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VREX Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 8–2 Matrix Metrics)

VREX Overall Winner 6-Pillar Tally: KIDS 2 – 3 VREX (1 Tie) Matrix Metrics: KIDS 2 – 8 VREX

As of Nov 19, 2026, Varex Imaging Corporation (VREX) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas VREX carries 63.4/100 (BUY) at $18.14 (16.9x Forward P/E, 8.3% operating margin).

  • Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile VREX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KIDS vs VREX
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86
VREX NASDAQ Head-to-Head Winner
Varex Imaging Corporation Common Stock
Electronic Components, Nec
$18.14
-0.06% 1D
Market Cap $772.2M
TTM Revenue $865M
Forward P/E 16.9x
Beta / 30D Vol 0.70β · 5% Vol
Unified Composite Score
63.4 / 100 BUY
Tech 65.0 Fund 59.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.3%) with fading momentum, RSI 31
RSI-14: 30.7 · SMA20: $18.36 · SMA50: $18.42

6-Pillar Scorecard Institutional Category Breakdown (KIDS 2 – 3 VREX)

Columns: Metric · KIDS · VREX
1. Valuation Multiples VREX
Forward P/E N/M 16.9x
Trailing P/E N/M 34.3x
PEG Ratio N/M 6.30x
EV / Revenue 3.2x 0.9x
2. Growth & Scale KIDS
Revenue Growth (YoY) +18.6% +3.7%
Earnings Growth (YoY) +0.0% +453.4%
TTM Revenue (USD) $264M $865M
Market Cap $850.2M $772.2M
3. Profitability & Quality VREX
Gross Margin 73.8% 34.3%
Operating Margin -8.2% 8.3%
Net Profit Margin -12.8% 2.6%
Return on Equity (ROE) -9.8% 4.6%
4. Balance Sheet & Cash Flow VREX
Cash Generation (TTM) $1.1M EBITDA $100M EBITDA
Cash Flow Margin 0.4% EBITDA Mgn 11.5% EBITDA Mgn
Net Cash / Leverage $12.99 Book/Sh · -9.8% ROE $11.78 Book/Sh · 4.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 145.1% (100th %ile) 112.0% (18th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 82.0% of Rev ($217M) 26.0% of Rev ($225M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KIDS (2) vs VREX (8)
Institutional Metric KIDS VREX Criterion Row Edge
Market Capitalization
Scale
$850.2M $772.2M Larger Scale KIDS
Trailing P/E Ratio
Valuation
N/M 34.3x Lower Multiple VREX
Forward P/E Ratio
Valuation
N/M 16.9x Lower Multiple VREX
Revenue Growth (YoY)
Growth
+18.6% +3.7% Higher Growth KIDS
Operating Margin (TTM)
Profitability
-8.2% 8.3% Higher Margin VREX
Net Profit Margin
Profitability
-12.8% 2.6% Higher Margin VREX
Return on Equity (ROE)
Capital Efficiency
-9.8% 4.6% Higher ROE VREX
52-Week Range Position
Momentum
90% ($14–$35) 95% ($9–$19) Stronger Trend VREX
Beta / 30D Volatility
Risk Regime
0.81β · 108% Vol 0.70β · 5% Vol Lower Realized Risk VREX
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 63.4 / 100 (BUY) Higher Composite VREX
Trailing 12M Revenue (USD)
Operating Scale
$264M $865M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.8% 34.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev 6.30x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) $100M EBITDA ($11.78 Book/Sh · 4.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +37.89 pp
KIDS: +36.37% · VREX: -1.52%
3M Horizon KIDS +28.74 pp
KIDS: +26.74% · VREX: -2.0%
6M Horizon VREX +2.67 pp
KIDS: +76.4% · VREX: +79.07%
1Y Horizon KIDS +45.89 pp
KIDS: +98.84% · VREX: +52.95%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KIDS vs VREX. Trailing 12-month operating profitability (KIDS -8.2% vs VREX 8.3%) and valuation multiples (KIDS N/M vs VREX 16.9x Forward P/E) are benchmarked directly in Pillar 4 below.

KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M
VREX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$865M
Gross Margin34.3%
Op. Margin8.3%
ROE / Fwd P/E4.6% · 16.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VREX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 112.0%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VREX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published
VREX Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $772.2M market capitalization and 8.3% operating margin.
OpEx & R&D Reinvestment 26.0% of Rev ($225M)
90D Engineering Disclosures 0 Published

Investor FAQ KIDS vs VREX Key Questions & Quantitative Answers

As of Nov 19, 2026, Varex Imaging Corporation (VREX) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas VREX carries 63.4/100 (BUY) at $18.14 (16.9x Forward P/E, 8.3% operating margin). Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile VREX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KIDS leads the Growth & Scale pillar: KIDS posts +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin), compared with VREX at +3.7% YoY revenue growth and +453.4% YoY earnings growth on $865M TTM revenue (34.3% gross margin, 8.3% operating margin). On trailing 12-month operating scale, KIDS generates $264M in USD-normalized revenue versus $865M for VREX. In operating R&D and SG&A reinvestment, KIDS deploys 82.0% of Rev ($217M) (0 90-day corporate R&D disclosures) versus 26.0% of Rev ($225M) (0 disclosures) for VREX.

VREX screens cheaper on headline valuation multiples. KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin), whereas VREX trades at 16.9x Forward P/E, 34.3x Trailing P/E, 6.30x PEG, and 0.9x EV/Revenue (11.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KIDS (-9.8% ROE) versus VREX (4.6% ROE) capital efficiency.

In options market volatility and institutional positioning, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk). By comparison, VREX carries 112.0% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.70β · 5% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.